https://www.selleckchem.com/pr....oducts/Atazanavir.ht
The impact of increasing recipient age on morbidity and mortality following living donor liver transplant (LDLT) remains controversial. The study aims to analyse the impact of recipient age on outcomes following LDLT. Adult LDLTs performed between November 2009 to February 2020 were retrieved from a prospectively maintained database. Patients were stratified into two groups based on recipient age 18-65 years (younger adults) and 65 years (older adults). Propensity score matching (PSM) using nearest-neighbour matching was used to
Curtir
Comentario
Compartilhar
